TKT and neoplasm: The EML4‐ALK fusion protein is expressed in lung under the transcriptional control of EML4 promoter, and the dimerization domain of EML4 permits unregulated dimerization of the TK domain, persistently activating downstream pathways that lead to tumor formation [33, 37, 38].